Loading
RP
RespireRx Pharmaceuticals Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Lippa Arnold, was filed 14 Sept 2018.
RespireRx Pharmaceuticals Inc.: what insiders have been doing
Every trade that managers of RespireRx Pharmaceuticals Inc. disclose to SEC (Form 4) is tracked on this page. RespireRx Pharmaceuticals Inc. has had no insider filing for more than a year; the last one goes back to 2 October 2020.
Over the whole record (from 2006), the tally stands at 36 purchases and 29 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
114
Thresholds
n/a
Buy Volume
€724,583
36 ops. · all time
Sell Volume
€248,057
29 ops. · all time
Financial data
as of FY 2015FY ended December 2015 · cache
Income statement
Revenue77.5k
Net income-1.9M-2419.3% margin
Last declaration on 2 October 2020
Declarations114 total
4,409,063 sharesCommon StockSEC:0001493152-20-018823:0
91,871,094 sharesCommon StockSEC:0001493152-20-018818:0
5,017,144 sharesCommon StockSEC:0001493152-20-018818:1
5,017,144 sharesCommon StockSEC:0001493152-20-018818:2
4,500,000 sharesCommon StockSEC:0001363763-20-000002:0
4,250,000 shares0Common StockSEC:0001363763-20-000002:1
4,250,000 shares0Common StockSEC:0001363763-20-000002:2
125,000 shares0Common StockSEC:0001363763-20-000002:3
125,000 shares0Common StockSEC:0001363763-20-000002:4
125,000 shares0Common StockSEC:0001363763-20-000002:5
125,000 shares0Common StockSEC:0001363763-20-000002:6
4,500,000 sharesCommon StockSEC:0001363763-20-000001:0
4,500,000 shares0Common StockSEC:0001363763-20-000001:1
47,620 sharesCommon StockSEC:0001363763-18-000001:0
Canonical exit: 11 Dec 2018 (T+90)
47,620 shares0Common stockSEC:0001363763-18-000001:1
1,097 sharesCommon StockSEC:0001573202-17-000009:0
Canonical exit: 12 Dec 2017 (T+90)
10,134,944 shares0Common StockSEC:0001363763-16-000029:0
10,000,000 shares0Common StockSEC:0001363763-16-000029:1
134,944 shares0Common StockSEC:0001363763-16-000029:2
5,000,000 shares0Common StockSEC:0001363763-16-000029:3
1,000,000 shares0Common StockSEC:0001363763-16-000029:4
4,000,000 shares0Common StockSEC:0001363763-16-000029:5
5,000,000 shares0Common StockSEC:0001363763-16-000028:0
5,000,000 shares0Common StockSEC:0001363763-16-000028:1
11,887,779 sharesCommon StockSEC:0001363763-16-000026:0
25 of 114 declarations
About RespireRx Pharmaceuticals Inc.
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for respiratory and neurological disorders. It aims to provide innovative therapies to improve patients' quality of life.
